Login to Your Account

Genelabs' Prestara Headed For New Phase III Lupus Trial

By Jennifer Boggs

Tuesday, January 17, 2006
Forging ahead with its lupus drug, Prestara, Genelabs Technologies Inc. has decided to conduct another Phase III trial, and likely will look for a development partner to help offset costs. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription